Rapid medical countermeasure response to infectious diseases : enabling sustainable capabilities through ongoing public- and private-sector partnerships : workshop summary

"Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical...

Full description

Main Author: Wizemann, Theresa M.
Corporate Authors: Institute of Medicine (U.S.) Forum on Medical and Public Health Preparedness for Catastrophic Events, Institute of Medicine (U.S.) Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.) Forum on Microbial Threats, Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases (Workshop) (2015, Washington, D.C.)
Other Authors: Snair, Megan Reeve ([rapporteur]), Herrmann, Jack ([rapporteur])
Format: eBook
Language:English
Published: Washington, D.C. National Academies Press [2016], 2016
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:"Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical countermeasures (MCMs) before an emerging infectious disease becomes a public health emergency in the United States has been extremely challenging. Interest and momentum peak during a crisis and wane between events, and there is little interest in disease threats outside the United States until they impact people stateside. On March 26 and 27, 2015, the Institute of Medicine convened a workshop in Washington, DC to discuss how to achieve rapid and nimble MCM capability for new and emerging threats. Public- and private-sector stakeholders examined recent efforts to prepare for and respond to outbreaks of Ebola Virus Disease, pandemic influenza, and coronaviruses from policy, budget, and operational standpoints. Participants discussed the need for rapid access to MCM to ensure national security and considered strategies and business models that could enhance stakeholder interest and investment in sustainable response capabilities. This report summarizes the presentations and discussions from this workshop"--Publisher's description
Item Description:"Agenda, March 26-27, 2015, Room 125 of the National Academy of Sciences Building, 2101 Constitution Avenue, NW, Washington, DC 20418: Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases: an Institute of Medicine Workshop"--Page 115
Physical Description:1 PDF file (xix, 156 pages) color illustrations
ISBN:0309378613
9780309378628
0309378621
9780309378611